Design Therapeutics Inc (DSGN)
$10.68 -3.44% Close Oct 30, 2026 Live
Design Therapeutics stock today
Design Therapeutics closed at $10.68 on October 30, 2026, down 3.44% on the day. Over the past year it returned +63.6% with dividends reinvested, against +12.4% for the S&P 500. Its market value is $667 million.
$10.00$15.00
NovJan 2026MarMayJulSep
| Period | DSGN | S&P 500 (SPY) |
|---|---|---|
| 1 month | -15.0% | -0.9% |
| 3 months | -15.4% | +2.1% |
| Year to date | +13.9% | +11.7% |
| 1 year | +63.6% | +12.4% |
| 3 years | +423.5% | +88.5% |
| 5 years | -31.9% | +76.0% |
Key statistics
- Market value
- $667M
- 52-week range
- $6.24 to $15.94
- Next report
- Nov 5, 2026 (estimated)
About Design Therapeutics
Design Therapeutics develops gene therapy treatments for genetic disorders affecting the nervous system.
Sector: Health Care
More on Design Therapeutics
- Returns: what $1,000 became$1,000 five years ago is $681.12 today
No forecast, no recommendation. This page describes Design Therapeutics Inc from published data; it is not advice to buy, sell or hold any security.
Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.